blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1542674

EP1542674 - CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.07.2017
Database last updated on 27.07.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
The National Institute of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325
Rockville, MD 20852 / US
[2016/36]
Former [2005/25]For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
The National Institute of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325
Rockville, MD 20852 / US
Inventor(s)01 / BOYD, Michael, R.
109 Austill Avenue
Mobile, AL 36608 / US
02 / GUSTAFSON, Kirk, R.
6782 Sunny Brook Drive
Frederick, MD 21702 / US
 [2005/25]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2016/36]
Former [2005/25]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Maximilianstrasse 58
80538 München / DE
Application number, filing date03751813.124.07.2003
[2005/25]
WO2003US23290
Priority number, dateUS20020398092P24.07.2002         Original published format: US 398092 P
[2005/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004009079
Date:29.01.2004
Language:EN
[2004/05]
Type: A1 Application with search report 
No.:EP1542674
Date:22.06.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 29.01.2004 takes the place of the publication of the European patent application.
[2005/25]
Type: B1 Patent specification 
No.:EP1542674
Date:07.09.2016
Language:EN
[2016/36]
Search report(s)International search report - published on:US29.01.2004
(Supplementary) European search report - dispatched on:EP04.09.2006
ClassificationIPC:A61K31/351, C07D309/06, A61P35/00, C07D498/08
[2006/40]
CPC:
C07D498/08 (EP,US); A61P13/00 (EP); A61P15/08 (EP);
A61P19/08 (EP); A61P19/10 (EP); A61P25/28 (EP);
A61P27/06 (EP); A61P31/10 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P35/04 (EP); C07D309/06 (EP,US) (-)
Former IPC [2005/25]A61K31/351, C07D309/06
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2016/36]
Former [2005/25]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL16.02.2005
LT16.02.2005
LV16.02.2005
MK16.02.2005
TitleGerman:ANTITUMORALE V-ATPASE-HEMMER-VERBINDUNGEN DER CHONDROPSIN-KLASSE, ZUSAMMENSETZUNGEN UND ANWENDUNGSVERFAHREN DAFÜR[2015/46]
English:CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF[2005/25]
French:COMPOSES D'INHIBITEUR DE V-ATPASE ANTITUMORAL DE LA CLASSE DES CHONDROPSINES, COMPOSITIONS ET METHODES D'UTILISATION DE CES DERNIERS[2005/25]
Former [2005/25]ANTITUMORALE V-ATPASE-HEMMER-VERBINDUNGEN DER CHONDROPSIN-KLASSE, ZUSAMMENSETZUNGEN UND ANWENDUNGSVEFAHREN DAF R
Entry into regional phase16.02.2005National basic fee paid 
16.02.2005Search fee paid 
16.02.2005Designation fee(s) paid 
16.02.2005Examination fee paid 
Examination procedure07.01.2004Request for preliminary examination filed
International Preliminary Examining Authority: US
16.02.2005Amendment by applicant (claims and/or description)
16.02.2005Examination requested  [2005/25]
18.07.2008Despatch of a communication from the examining division (Time limit: M04)
03.11.2008Reply to a communication from the examining division
12.10.2015Communication of intention to grant the patent
15.02.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
31.03.2016Communication of intention to grant the patent
11.07.2016Fee for grant paid
11.07.2016Fee for publishing/printing paid
11.07.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.07.2008
Opposition(s)08.06.2017No opposition filed within time limit [2017/33]
Fees paidRenewal fee
20.07.2005Renewal fee patent year 03
27.07.2006Renewal fee patent year 04
27.07.2007Renewal fee patent year 05
25.07.2008Renewal fee patent year 06
28.07.2009Renewal fee patent year 07
26.07.2010Renewal fee patent year 08
25.07.2011Renewal fee patent year 09
25.07.2012Renewal fee patent year 10
29.07.2013Renewal fee patent year 11
28.07.2014Renewal fee patent year 12
27.07.2015Renewal fee patent year 13
27.07.2016Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.07.2003
AT07.09.2016
BE07.09.2016
CY07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
IT07.09.2016
MC07.09.2016
NL07.09.2016
RO07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
TR07.09.2016
BG07.12.2016
GR08.12.2016
PT09.01.2017
[2020/15]
Former [2019/46]HU24.07.2003
AT07.09.2016
BE07.09.2016
CY07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
IT07.09.2016
MC07.09.2016
NL07.09.2016
RO07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
BG07.12.2016
GR08.12.2016
PT09.01.2017
Former [2019/31]HU24.07.2003
AT07.09.2016
BE07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
IT07.09.2016
MC07.09.2016
NL07.09.2016
RO07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
BG07.12.2016
GR08.12.2016
PT09.01.2017
Former [2019/30]AT07.09.2016
BE07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
IT07.09.2016
MC07.09.2016
NL07.09.2016
RO07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
BG07.12.2016
GR08.12.2016
PT09.01.2017
Former [2017/37]AT07.09.2016
BE07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
IT07.09.2016
NL07.09.2016
RO07.09.2016
SE07.09.2016
SI07.09.2016
SK07.09.2016
BG07.12.2016
GR08.12.2016
PT09.01.2017
Former [2017/34]AT07.09.2016
BE07.09.2016
CZ07.09.2016
DK07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
IT07.09.2016
NL07.09.2016
RO07.09.2016
SE07.09.2016
SK07.09.2016
BG07.12.2016
GR08.12.2016
PT09.01.2017
Former [2017/32]AT07.09.2016
BE07.09.2016
CZ07.09.2016
EE07.09.2016
ES07.09.2016
FI07.09.2016
IT07.09.2016
NL07.09.2016
RO07.09.2016
SE07.09.2016
SK07.09.2016
BG07.12.2016
GR08.12.2016
PT09.01.2017
Former [2017/13]ES07.09.2016
FI07.09.2016
NL07.09.2016
SE07.09.2016
GR08.12.2016
Former [2017/12]ES07.09.2016
FI07.09.2016
SE07.09.2016
GR08.12.2016
Former [2017/10]FI07.09.2016
SE07.09.2016
Documents cited:Search[X]WO0208231  (US HEALTH [US], et al) [X] 1-15* the whole document *
International search[A]WO0051589  (US HEALTH [US], et al)
 [XP]  - RASHID M.A. ET AL., "Application of high-field NMR and cryogenic probe technologies in the structural elucidation of Poecillastrin A, a new antitumor macrolide lactam from the sponge Poecillastra species", ORGANIC LETTERS, (200208), vol. 4, no. 19, pages 3293 - 3296, XP002969700

DOI:   http://dx.doi.org/10.1021/ol026564k
 [A]  - RASHID M.A. ET AL., "New chondropsin macrolide lactams from marine sponges in the genus Ircinia", TETRAHEDRON LETTERS, (2001), vol. 42, pages 1623 - 1626, XP002970101

DOI:   http://dx.doi.org/10.1016/S0040-4039(00)02348-0
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.